A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved

by | Mar 19, 2026 | Stock Market

Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.

Article Attribution | Read More at Article Source